SK2002001A3 - New 4-amino-1-aryl-pyridine-2-ones with anticonvulsive action and method for producing same - Google Patents

New 4-amino-1-aryl-pyridine-2-ones with anticonvulsive action and method for producing same Download PDF

Info

Publication number
SK2002001A3
SK2002001A3 SK200-2001A SK2002001A SK2002001A3 SK 2002001 A3 SK2002001 A3 SK 2002001A3 SK 2002001 A SK2002001 A SK 2002001A SK 2002001 A3 SK2002001 A3 SK 2002001A3
Authority
SK
Slovakia
Prior art keywords
amino
pyridin
formula
compounds
preparation
Prior art date
Application number
SK200-2001A
Other languages
English (en)
Slovak (sk)
Inventor
Hans-Joachim Lankau
Klaus Unverferth
Thomas Arnold
Reni Bartsch
Angelika Rostock
Vladimir Granik
Sofia Grizik
Original Assignee
Dresden Arzneimittel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dresden Arzneimittel filed Critical Dresden Arzneimittel
Publication of SK2002001A3 publication Critical patent/SK2002001A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SK200-2001A 1998-08-07 1999-07-28 New 4-amino-1-aryl-pyridine-2-ones with anticonvulsive action and method for producing same SK2002001A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19835918A DE19835918A1 (de) 1998-08-07 1998-08-07 Neue antikonvulsiv wirkende 4-Amino-1-aryl-pyridin-2-one und Verfahren zu deren Herstellung
PCT/EP1999/005399 WO2000007988A1 (fr) 1998-08-07 1999-07-28 Nouvelle 4-amino-1-aryl-pyridine-2-one a proprietes anticonvulsivantes et son procede de fabrication

Publications (1)

Publication Number Publication Date
SK2002001A3 true SK2002001A3 (en) 2002-01-07

Family

ID=7876889

Family Applications (1)

Application Number Title Priority Date Filing Date
SK200-2001A SK2002001A3 (en) 1998-08-07 1999-07-28 New 4-amino-1-aryl-pyridine-2-ones with anticonvulsive action and method for producing same

Country Status (21)

Country Link
US (1) US6071911A (fr)
EP (1) EP1102748A1 (fr)
JP (1) JP2002522420A (fr)
KR (1) KR20010074802A (fr)
CN (1) CN1322197A (fr)
AR (1) AR021186A1 (fr)
AU (1) AU5507499A (fr)
BG (1) BG105196A (fr)
BR (1) BR9912849A (fr)
CA (1) CA2279692C (fr)
DE (1) DE19835918A1 (fr)
HU (1) HUP0103204A3 (fr)
IL (1) IL141200A0 (fr)
NO (1) NO20010575L (fr)
NZ (1) NZ509914A (fr)
PL (1) PL346013A1 (fr)
RU (1) RU2001106634A (fr)
SK (1) SK2002001A3 (fr)
TR (1) TR200100370T2 (fr)
WO (1) WO2000007988A1 (fr)
ZA (1) ZA200100999B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2320973T3 (es) 2000-06-12 2009-06-01 EISAI R&D MANAGEMENT CO., LTD. Compuestos de 1,2-dihidropiridina, procedimiento para su preparacion y uso de los mismos.
GB0129260D0 (en) 2001-12-06 2002-01-23 Eisai London Res Lab Ltd Pharmaceutical compositions and their uses
MY148809A (en) 2004-07-06 2013-05-31 Eisai R&D Man Co Ltd Crystals of 1,2-dihydropyridine compound and their production process
KR20210107644A (ko) 2018-12-14 2021-09-01 에자이 알앤드디 매니지먼트 가부시키가이샤 1,2-디하이드로피리딘 화합물의 수성 기반 약학적 제형

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51118768A (en) * 1975-02-19 1976-10-18 Shigeo Senda Method for preparing 4-amino-2-pyridone derivatives
EP0110091B1 (fr) * 1982-10-27 1987-01-21 Degussa Aktiengesellschaft Dérivés de la 2-amino-3-acylamino-6-benzylamino-pyridine à activité antiépileptique

Also Published As

Publication number Publication date
KR20010074802A (ko) 2001-08-09
AU5507499A (en) 2000-02-28
NO20010575L (no) 2001-04-04
JP2002522420A (ja) 2002-07-23
BR9912849A (pt) 2001-05-08
CN1322197A (zh) 2001-11-14
CA2279692A1 (fr) 2000-02-07
NO20010575D0 (no) 2001-02-02
AR021186A1 (es) 2002-07-03
ZA200100999B (en) 2001-12-14
HUP0103204A3 (en) 2002-06-28
TR200100370T2 (tr) 2001-08-21
DE19835918A1 (de) 2000-02-10
NZ509914A (en) 2002-11-26
HUP0103204A2 (hu) 2002-04-29
PL346013A1 (en) 2002-01-14
BG105196A (en) 2001-12-29
US6071911A (en) 2000-06-06
IL141200A0 (en) 2002-02-10
EP1102748A1 (fr) 2001-05-30
RU2001106634A (ru) 2004-02-27
WO2000007988A1 (fr) 2000-02-17
CA2279692C (fr) 2003-10-07

Similar Documents

Publication Publication Date Title
JP5699152B2 (ja) リジン特異的デメチラーゼ−１阻害剤およびその使用
JP5868948B2 (ja) リジン特異的脱メチル化酵素１阻害薬およびその使用
ZA200307372B (en) Thiohydantoins and use thereof for treating diabetes.
US5164397A (en) 2-aminopyrimidine-4-carboxamide derivatives, their preparation and their application in urinary therapeutics
DD263980A5 (de) Verfahren zur herstellung von neuen diphenyl-propylamin-derivaten
DE2046595A1 (de) Oxindolcarboxamide und deren pharmazeutisch vertragliche Basen additionssalze sowie Verfahren zu deren Herstellung
EP0000220B1 (fr) Dihydrouraciles, procédé pour leur préparation et médicaments les contenant
IE832058L (en) 1,4-dihydropyridine derivatives
CH500987A (de) Neues Verfahren zur Herstellung von 2-Arylamino-1,3-diazacycloalkenen-(2)
FR2567519A1 (fr) Nouvelles isoindolinyl-alcoyl-piperazines, compositions pharmaceutiques les contenant, et leur procede de preparation
SK2002001A3 (en) New 4-amino-1-aryl-pyridine-2-ones with anticonvulsive action and method for producing same
Mull et al. Antihypertensively active amidoximes
CZ2001450A3 (cs) Nové 4-amino-l-arylpyridin-2-ony, které mají antikonvulsivní účinek a způsob jejich přípravy
PL188287B1 (pl) Nowe, 1-fenyloalkilo-imidazolino-2-ony, sposób ich wytwarzania, preparat farmaceutyczny zawierającyte pochodne oraz ich zastosowanie do wytwarzania leków do leczenia schorzeń epileptycznych
JP2005534701A (ja) アミノアルキル置換アリール化合物及びナトリウムチャネルブロッカーとしてのそれらの使用
JP3786983B2 (ja) ピロリジノン誘導体
CZ148595A3 (en) Novel phenylethyl amines and phenylpropyl amines, process of their preparation and pharmaceutical composition containing thereof
EP0109636B1 (fr) Dérivés de benzazépine, leur procédé de préparation et leur application comme médicaments
DE2753878A1 (de) Derivate des 1-(3,5-dichlorphenyl)- piperazins, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US3382260A (en) Novel sulfonamide compounds and processes
EP0175293A1 (fr) Lactames bicycliques, procédés pour leur préparation, leur utilisation et compositions les contenant
EP0579129A2 (fr) Dérivés de thiadiazole pour le traitement des états dépressifs
CH535207A (de) Verfahren zur Herstellung eines Amidins
US2820800A (en) Reaction of methylenebis acrylamide and a furane amine
DE2419386A1 (de) Neue 6-aza-3h-1,4-benzodiazepine